Elevated levels of various m6A regulatory proteins (METTL3, METTL14, ALKBH5, FTO, WTAP, etc.)are observed in cerebrospinal fluid from MS patients, suggesting their potential roles in MS pathogenesis [65] (Figure 4). This evidence concerns the gene METTL14 and myeloid sarcoma.